Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes (2022)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1016/j.clml.2021.08.004
- Subjects: PROGNÓSTICO; MARCADORES BIOLÓGICOS; LINFOMA
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical lymphoma myeloma & leukemia
- ISSN: 2152-2650
- Volume/Número/Paginação/Ano: v. 22, n. 2, p. 67-75, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NOGUEIRA, Daniel Silva et al. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes. Clinical lymphoma myeloma & leukemia, v. 22, n. 2, p. 67-75, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clml.2021.08.004. Acesso em: 11 fev. 2026. -
APA
Nogueira, D. S., Lage, L. A. de P. C., Culler, H. F., & Pereira, J. (2022). Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes. Clinical lymphoma myeloma & leukemia, 22( 2), 67-75. doi:10.1016/j.clml.2021.08.004 -
NLM
Nogueira DS, Lage LA de PC, Culler HF, Pereira J. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 2): 67-75.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.clml.2021.08.004 -
Vancouver
Nogueira DS, Lage LA de PC, Culler HF, Pereira J. Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes [Internet]. Clinical lymphoma myeloma & leukemia. 2022 ; 22( 2): 67-75.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/j.clml.2021.08.004 - Adult T-Cell Leukemia/Lymphoma: A Clinical and Epidemiological Analysis at the Medicine School of Sao Paulo University
- How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation
- Radiographic patterns of multiple myeloma in the jawbones of patients treated with intravenous bisphosphonates
- GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
- Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study
- Panoramic and skull imaging may aid in the identification of multiple myeloma lesions
- Estudo de células precuroras em leucemias agudas: identificação e fator de prognóstico das proteínas Bcl-2, Bax e CD95/Fas/APO-1
- Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study
- 18 F-FDG pet interim and determination of cellular origin by immunohistochemistry identify a group of very good prognosis in patients with diffuse large B cell lymphoma in the rituximab era
- Immune reconstitution inflammatory syndrome-associated lymphoma: a retrospective Brazilian cohort
Informações sobre o DOI: 10.1016/j.clml.2021.08.004 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
